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Autophagy is a stress response protecting cells from
unfavorable conditions, such as nutrient starvation.
The class III phosphatidylinositol-3 kinase, Vps34,
forms multiple complexes and regulates both intra-
cellular vesicle trafficking and autophagy induction.
Here, we show that AMPK plays a key role in regu-
lating different Vps34 complexes. AMPK inhibits the
nonautophagy Vps34 complex by phosphorylating
T163/S165 in Vps34 and therefore suppresses
overall PI(3)P production and protects cells from
starvation. In parallel, AMPK activates the proau-
tophagy Vps34 complex by phosphorylating S91/
S94 in Beclin1 to induce autophagy. Atg14L, an auto-
phagy-essential gene present only in the proautoph-
agy Vps34 complex, inhibits Vps34 phosphorylation
but increases Beclin1 phosphorylation by AMPK.
As such, Atg14L dictates the differential regulation
(either inhibition or activation) of different Vps34
complexes in response to glucose starvation. Our
study reveals an intricate molecular regulation of
Vps34 complexes by AMPK in nutrient stress
response and autophagy.
INTRODUCTION
Autophagy is a catabolic process that maintains cellular homeo-
stasis in response to a wide spectrum of cellular stresses, such
as nutrient starvation, infection, damaged organelles, and pro-
tein aggregates (Mizushima, 2007; Yang and Klionsky, 2010).
These processes are coordinated by ATG proteins; among
them the ULK1 and Vps34 complexes are well known to function
as important regulators in autophagy initiation and progression
(Nakatogawa et al., 2009; Suzuki et al., 2007).
Vps34 is a class III PI3K that phosphorylates the 3-position of
phosphatidylinositol to produce phosphatidylinositol-(3)-phos-290 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.phate (PI(3)P), which is a key membranemarker for both intracel-
lular trafficking and autophagosome formation (Backer, 2008).
PI(3)P functions to recruit proteins with PI(3)P binding domains,
such as FYVE or PX domain, to modulate membrane activity
(Obara and Ohsumi, 2011). Extensive yeast genetic and bio-
chemical analyses have established that Vps34 forms multiple
complexes that are responsible for its different cellular functions
(Kametaka et al., 1998; Kihara et al., 2001; Obara et al., 2006).
The autophagy-specific Vps34 complex consists of Vps34,
Vps15, Atg6/Vps30, and Atg14 (complex I). In parallel, Atg6/
Vps30 interacts with Vps38 to form the distinctive Vps34
complex II, which is required for endosome-to-Golgi retrograde
trafficking.
The mammalian Vps34 also exists in different complexes and
is involved in a variety of cellular functions, such asmultivesicular
body pathway, retrograde trafficking from endosomes to the
Golgi, phagosome maturation, and autophagy (Backer, 2008).
Core components of the Vps34 complexes include Vps34 and
p150 (Vps15). Beclin1, a mammalian homolog of Atg6, partici-
pates in Vps34 complex formation and recruits additional
proteins, such as Atg14L/Barkor and UVRAG. Recent reports
demonstrated that Atg14L and UVRAG devote the Vps34
complex to autophagy (Liang et al., 2006; Matsunaga et al.,
2009; Sun et al., 2008). In addition, VMP1 (Ropolo et al., 2007),
Ambra-1 (Fimia et al., 2007), Bif-1 (Takahashi et al., 2007), and
Rubicon (Matsunaga et al., 2009) are also reported as compo-
nents of the Vps34 complex, suggesting that many different
Vps34 complexes are present and contribute to a wide range
of cellular regulations.
The complexity of Vps34 biology indicates that multiple layers
of regulation probably impinge on different complexes. Much
effort in understanding Vps34 function has been centered on
the interaction between Vps34 and Beclin1. The antiapoptotic
protein Bcl-2may inhibit autophagy by disrupting Vps34-Beclin1
interaction due to its competitive binding to Beclin1 (Pattingre
et al., 2005). JNK is suggested to phosphorylate Bcl-2 and disso-
ciate its interaction from Beclin1 (Wei et al., 2008). DAP-kinase
andCDK1/5 are also reported to regulate Vps34-Beclin1 interac-
tion through phosphorylation (Furuya et al., 2010; Zalckvar et al.,
2009). Although the Vps34 complex has long been believed to
have a critical role in autophagy, it is not even clear whether
Vps34 lipid kinase is activated upon the autophagy-inducing
conditions. Also, it remains to be determined how the lipid kinase
activity of different Vps34 complexes is regulated and whether
there is coordination of these different Vps34 complexes under
starvation.
AMPK is a key cellular energy sensor and functions tomaintain
energy homeostasis upon nutrient starvation (Hardie, 2007).
Lines of evidence support a role of AMPK in autophagy induc-
tion, including ULK1 activation, in response to nutrient starvation
(Egan et al., 2011; Kim et al., 2011). In this study, we show
a molecular mechanism underlying differential regulations of
pro- and nonautophagy Vps34 complexes by AMPK in nutrient
stress and autophagy. These intricate regulations are accom-
plished by a direct phosphorylation of Vps34 T163/S165 and
Beclin1 S91/S94 by AMPK under the control of autophagy-
specific subunits, such as Atg14L.
RESULTS
Activity of Different Vps34 Complexes Is Differentially
Regulated by Glucose Starvation
To study the regulation of different Vps34 complexes upon auto-
phagy induction, we first measured the lipid kinase activity of
four different Vps34 complex pools from glucose-starved cells.
Four different Vps34 complexes were prepared by immunopre-
cipitation (IP) against Vps34, Beclin1, Atg14L, and UVRAG,
respectively. Glucose starvation decreased the lipid kinase
activity of IP isolated with antibody against Vps34 or Beclin1,
whereas the lipid kinase activity of IP isolated with antibody
against either Atg14L or UVRAG was increased by glucose star-
vation (Figure 1A). Notably, the basal Vps34 lipid kinase activity
in the Atg14L- and UVRAG-IP was much higher than that of
the Vps34- or Beclin1-IP. We performed western blotting to
determine the composition of the above IPs. When normalized
to Vps34 protein levels, we found that Vps34-IP contained
p150 (Vps15) and some Beclin1 but no detectable level of
Atg14L or UVRAG (Figure 1B). The Beclin1-IP contained
Vps34, p150, and some Atg14L, but little UVRAG. The Atg14L
and UVRAG-IPs contained Vps34, p150, Beclin1, and Atg14L
or UVRAG in amutually exclusivemanner, as previously reported
(Itakura et al., 2008). Notably, glucose starvation had almost no
effect on Vps34 protein levels in each IP (Figure 1A), indicating
that the starvation-induced changes in Vps34 activity were not
due to alteration of the composition of each Vps34 complex.
Similar IP analyses in different cell lines suggest that the stoichi-
ometry of the Vps34 complex varies in the cell lines. For
example, themajority of Vps34 exists as an Atg14L-free complex
in MEFs and NIH 3T3, but a significant amount of Atg14L was
observed in Vps34-IP from HeLa cells, possibly due to different
expression levels of Beclin1 and Atg14L (Figure S1A).
To further explore the relative abundance of different Vps34
complexes in MEFs, we performed quantitative immunodeple-
tion with increasing amounts of antibodies (Figure 1C). Quantita-
tive removal of Vps34 resulted in an effective depletion of p150,
Beclin1, and Atg14L and a significant decrease of UVRAG, indi-
cating that most of Beclin1 and Atg14L are associated withVps34. Quantitative removal of Beclin1 fully depleted Atg14L
but a significant amount of Vps34 and p150 still remained in
the post-IP supernatant, suggesting the existence of a large
amount of Beclin1-free Vps34 complex in MEFs. Importantly,
Atg14L immunodepletion did not effectively reduce Vps34 or
Beclin1, indicating that the majority of Vps34 or Beclin1 is not
associated with Atg14L. Immunodepletion of Atg14L or UVRAG
did not affect the levels of UVRAG or Atg14L, respectively, con-
firming a mutually exclusive association of Atg14L and UVRAG
with the Vps34 complex. The above data demonstrate the exis-
tence of four distinct Vps34 complexes and their relative abun-
dance in MEFs.
The reduction in lipid kinase activity from Beclin1-IP is quite
perplexing because it also contains Atg14L, although at
a much reduced level. To further investigate the differential regu-
lation of different Vps34 complexes, we attempted to obtain
a highly enriched individual Vps34 population as outlined in Fig-
ure S1B. For simplicity, we named them Vps34-containing PI3K-
III Complex 1 (VIC1), labeled as Vps34, VIC2 (Beclin1), VIC3
(Atg14L), and VIC4 (UVRAG). The compositions of these four
complexes were confirmed by western blots. As shown in Fig-
ure 1D, purification and fractionation successfully provided an
individual Vps34 complex, as anticipated. Consistent with Fig-
ure 1A, the lipid kinase assay clearly showed that VIC3 and
VIC4 were activated, but VIC1 and VIC2 were inhibited by
glucose starvation (Figure 1E). The activities of VIC1 and VIC2
were low, but further decreased upon the starvation. Our data
clearly demonstrate that different Vps34 complexes are differen-
tially regulated in response to glucose starvation.
AMPK Is Required for Glucose-Starvation-Induced
Vps34 Regulation
As a primary energy source, glucose starvation results in cellular
energy depletion and concomitantly activates AMPK, which is
important for autophagy induction. Therefore, we tested whether
AMPK is required for the regulation of Vps34 complexes in
response to glucose starvation, in which AMPK was activated
as evidenced by the increased phosphorylation of AMPK and
its substrate, ACC (Figure S1C). In this experimental setting,
we determined Vps34 lipid kinase activity in AMPKa wild-type
(WT) and a1/a2 double-knockout (DKO) mouse embryonic fibro-
blasts (MEFs). Notably, the regulation of Vps34 complex activity
by glucose starvation was blunted in AMPKa-DKO MEFs both
for VIC1 and VIC2 inhibition and for VIC3 and VIC4 activation
(Figure 1F).
To further confirm a role of AMPK in glucose-starvation-
induced Vps34 regulation, we immunopurified the four different
Vps34 complexes from HEK293 cells cotransfected with
a kinase-inactive AMPKa (AMPK-DN). Expression of AMPK-DN
diminished the effect of glucose starvation on Vps34 regulation
(Figure S1E). Moreover, coexpression of WT AMPKa inhibited
VIC1 and VIC2 but activated VIC3 and VIC4 even in the
glucose-rich condition (Figure S1F). Notably, the nonautophagy
Vps34 complexes VIC1 and VIC2 showed quite low lipid kinase
activity when normalized with Vps34 protein compared with
VIC3 and VIC4, which is consistent with the reports that
Atg14L and UVRAG activate Vps34 activity (Liang et al., 2006;
Zhong et al., 2009). Consistently, treatment with the AMPKCell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 291
Figure 1. Different Regulation of Vps34 Complexes by Glucose Starvation in a Manner Dependent on AMPK
(A) Regulation of Vps34 complexes by glucose starvation. WT MEF cells were starved for glucose for 3 hr as indicated, and the four Vps34-IP complexes were
assayed for PI(3)P lipid kinase activity (n = 4).
(B) Subunit composition of Vps34 complexes. Vps34 protein level in each preparation (A) was first examined (top) and then normalized to determine the subunit
composition of each of the complexes (lower panels). IP efficiency of each antibodywas examined by comparison of the target protein amount in the lysate before
(B) and after (A) IP.
(C) Relative abundance of Vps34 complexes. A quantitative immunodepletion assay was performed with increasing amounts of the indicated antibodies.
Supernatants of MEF lysates after immunodepletion (Post-IP) were examined to determine the level of Vps34 complex proteins.
(D) Preparation of four different highly enriched Vps34 complexes. Subunit composition was examined as described in (B).
(E) Glucose starvation inhibits VIC1 and VIC2 but activates VIC3 and VIC4. Four different Vps34 complexes in (D) were subjected to Vps34 lipid kinase assay (n = 3).
(F) AMPK is required for Vps34 regulation by glucose starvation. Endogenous Vps34 complexes were immunopurified from glucose-starved MEFs as in (A). The
Vps34 kinase activity was normalized by the Vps34 protein levels (Figure S1D) (n = 4).
Data are represented as mean ± S.D.; CON, mouse IgG-IP as a negative control. See also Figure S1.activators 2-DG or Metformin was sufficient to enhance VIC3
activity and suppress VIC2 activity (Figure S1G). Collectively,
these data demonstrate a critical role of AMPK in the differential
regulation of proautophagy (VIC3 and VIC4) and nonautophagy
(VIC1 and VIC2) Vps34 complexes in response to glucose
starvation.
AMPK Directly Regulates Vps34 Complex Activity
We asked whether AMPK could directly regulate Vps34 complex
activity. Four different endogenous Vps34 immune complexes
were incubated with AMPK in vitro in the presence of cold ATP
and then were subjected to Vps34 lipid kinase assay. Similar to
glucose starvation, in vitro AMPK treatment strongly inhibited292 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.VIC1 and VIC2 but activated VIC3 and VIC4 (Figure 2A). We
also performed in vitro AMPK treatment on pure Vps34 popula-
tions prepared by the procedure outlined in Figure S1B and ob-
tained the results (Figure 2B) similar to those shown in Figure 2A,
suggesting that AMPK plays a direct role in Vps34 regulation.
To verify that AMPK regulates Vps34 by phosphorylation,
we treated the Vps34 complex with both AMPK and lambda
phosphatase (l PPase) as outlined in Figure S2A. We found
that l PPase treatment reversed both the inhibitory effect of
AMPK on VIC1 and VIC2 and the activating effect on VIC3 (Fig-
ure 2C), indicating that AMPK regulates Vps34 complexes by
phosphorylation. Consistently, AMPK could not activate VIC3
in the absence of ATP during in vitro treatment (Figure S2B).
Figure 2. AMPK Directly Regulates Vps34 Complex through Phosphorylation
(A) AMPK directly regulates the Vps34 complex. The Vps34 complex was immunopurified from MEFs in a glucose-rich medium and incubated with AMPK for
15 min in vitro as indicated (n = 4).
(B) AMPK inhibits VIC1 and VIC2 but activates VIC3 and VIC4 in vitro. Four highly enriched Vps34 complexes obtained as in Figure 1D were treated with AMPK
in vitro and assayed for the lipid kinase assay (n = 3).
(C) AMPK regulates the Vps34 complex via phosphorylation. The indicated Vps34 complexes were immunopurified from MEFs in a glucose-rich condition. The
complexes were incubated with AMPK and l PPase as indicated by arrows for order of the treatment (n = 3).
(D) AMPK-mediated phosphorylation is necessary and sufficient for the regulation of Vps34 complexes by glucose starvation. The Vps34 complexes were
immunopurified from glucose-starved MEFs and then treated with AMPK and l PPase (n = 3).
(E) Atg14L converts the Vps34-Beclin1 complex from inhibition to activation by AMPK. Vps34-Beclin1 complex was immunopurified from U2OS cells, to which
purified Atg14L-Flag/6His protein was added. Also, Atg14L-containing Vps34 complex was directly prepared by Atg14L-IP from the cells as a control. The
immune complex was treated with AMPK in vitro and assayed for Vps34 lipid kinase assay (n = 2).
(F) Overexpression of Atg14L activates Vps34 kinase activity of Beclin1-IP in response to AMPK treatment. Vps34 complexes were immunopurified from the
U2OS cell lines overexpressing Atg14L, which was induced by DOX, and then incubated with AMPK in vitro before the lipid kinase assay, as indicated (n = 2).
Data are represented as mean ± S.D. See also Figure S2.Next, we investigated whether phosphorylation by AMPK plays
an important role in Vps34 regulation induced by glucose
starvation (Figure 2D). Dephosphorylation by l PPase treatment
activated VIC1 and VIC2 isolated from the glucose starvation
condition to levels similar to those isolated from unstarved cells.
Moreover, dephosphorylation inhibited the lipid kinase activity of
VIC3 isolated from glucose starvation. These results demon-
strate that phosphorylation is the major mechanism for Vps34
complex regulation by glucose starvation. Importantly, rephos-
phorylation of l PPase-treated Vps34 complexes by AMPK
was sufficient to inhibit VIC1 and VIC2 and to activate VIC3 (Fig-
ure 2D) to the level similar to the complexes from glucose-starved cells. A parallel experiment showed that l PPase or
AMPK treatment affected the UVRAG-containing VIC4 in a
manner similar to VIC3 regulation (Figure S2C). Collectively,
these data demonstrate that AMPK-dependent phosphorylation
is necessary and sufficient for Vps34 regulation (both inhibition of
nonautophagy VIC1 and VIC2 and activation of proautophagy
VIC3 and VIC4) in response to glucose starvation.
Atg14L Converts Vps34 Regulation from Inhibition
to Activation by AMPK
The lipid kinase activities of VIC2 and VIC3 show opposite
responses to glucose starvation as well as to AMPK treatment.Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 293
A key difference between VIC2 and VIC3 is the presence of the
autophagy-specific subunit Atg14L in VIC3. We hypothesized
that Atg14L may play a critical role in switching Vps34 regulation
from inhibition to activation by AMPK. To test this possibility,
we added purified Atg14L into the endogenous Beclin1-IP
(VIC2). In vitro addition of Atg14L to VIC2 increased the basal
activity in a dose-dependent manner (Figure S2D). The purified
Atg14L protein had no contaminating Vps34 activity (Figure S2E).
Importantly, addition of Atg14L switched VIC2 regulation by
AMPK from inhibition to activation (Figure 2E). Therefore,
Atg14L is a key factor for determining the effect (either inhibition
or activation) of AMPK on Vps34 complexes. Experiments
using several Atg14L deletion mutants further demonstrated
that the N-terminal 72 residues and the C-terminal BATS domain
of Atg14L are dispensable for Vps34 activation by AMPK
(Figure S2F).
One possible explanation for AMPK-induced inhibition of
Beclin1-IP is that only a very small fraction of Beclin1-IP contains
Atg14L (Figures 1B and 1C). Therefore, inhibition of the Atg14L-
free complex (VIC2) by AMPK overwhelmed the activating
effects of the very small fraction of Atg14L-contacting complex
(VIC3) in the Beclin-IP. If so, we reasoned that overexpression
of Atg14L should increase the fraction of endogenous Beclin1
in complex with Atg14L. As predicted, Beclin1-IP from the
Atg14L-overexpressing cells contained a higher level of the
ectopic Atg14L protein, which was comparable to endogenous
Atg14L in VIC3 when normalized to the Vps34 protein level (Fig-
ure 2F). As a consequence of increased Atg14L, the lipid kinase
activity of Beclin1-IP prepared from Atg14L-overexpressing
cells was indeed activated by AMPK. Collectively, these data
demonstrate that Atg14L plays a key role in determining whether
the Vps34 complex is inhibited (in the absence of Atg14L) or acti-
vated (in the presence of Atg14L) by AMPK.
AMPK Phosphorylates Vps34 and Beclin1
It is intriguing how AMPK exerts opposite effect on different
Vps34 complexes that have the same catalytic subunit. Consid-
ering that AMPK regulates the Vps34 complex by phosphoryla-
tion, we performed in vitro AMPK phosphorylation of individual
Vps34 complex subunits. We observed that Vps34 and Beclin1
were directly phosphorylated by AMPK in vitro (Figures 3A and
S3A). Based on mass spectrometry, systemic deletions, and
site-directed mutation, we identified S91 and S94 in Beclin1
(Figures S3B and S3C) and T163 and S165 in Vps34 (Figures
S3D and S3E) as the major AMPK phosphorylation sites.
Notably, the Beclin1 phosphorylation sites do not fit the conven-
tional AMPK consensusmotif (Gwinn et al., 2008). However, they
align with two AMPK phosphorylation sites (S317 and S777) in
ULK1 (Figure 3B) (Kim et al., 2011). Also, the AMPK site S79
in ACC1 fits this sequence defined as Bas-Hyd-X-S-X-X-pS/
T-X-X-X-Hyd (Bas and Hyd denote for basic and hydrophobic
residues, respectively). This may represent a new AMPK phos-
phorylation consensus sequence.
To confirm Vps34 and Beclin1 phosphorylations in vivo, we
generated phosphospecific antibodies for Beclin1 and Vps34
and confirmed that the antibodies preferentially recognized the
in vitro phosphorylated GST-Beclin1 and GST-Vps34 by AMPK
(Figure S3F). Using these phosphospecific antibodies, we294 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.observed that glucose starvation increased the phosphorylation
of endogenous Beclin1 S91/S94 and Vps34 T163/S165 (Fig-
ure 3C). Importantly, these phosphorylations were abolished in
AMPKa DKO MEFs, demonstrating that AMPK is required for
Beclin1 and Vps34 phosphorylation. Consistently, the AMPK
activators 2-DG and Metformin also increased phosphorylation
of Vps34 and Beclin1 even in glucose-rich conditions, whereas
an AMPK inhibitor, compound C, blocked glucose-starvation-
induced phosphorylations (Figure 3D). Moreover, the coexpres-
sion of WT AMPKa, but not the kinase inactive mutant, induced
phosphorylation of Beclin1 (Figure S3G) and Vps34 (Figure S3H)
even in glucose-rich conditions. These data establish a physio-
logical role for AMPK in the phosphorylation of Beclin1 S91/
S94 and Vps34 T163/S165 in response to glucose starvation.
Beclin1 Phosphorylation Is Required for Activation
of the Proautophagy Vps34 Complex
Next, we wished to determine the function of phosphorylation in
the regulation of Vps34 complexes. WT or phosphorylation-
defective mutants (SA, denoting mutants of serine substitution
by alanine) were coexpressed with Atg14L, and the Atg14L-
associated complex (VIC3) was immunoprecipitated to deter-
mine Vps34 lipid kinase activity. We found that VIC3 containing
the Beclin1 S91/94A (SA) could not be activated by glucose star-
vation or AMPK coexpression in vivo (Figure 4A), whereas the
complex containing Beclin1 WT was activated by both condi-
tions. This result suggests that phosphorylation of Beclin1 S91/
S94 is required for activation of the proautophagic Vps34 com-
plex VIC3 by AMPK or glucose starvation. Consistently, the
complex containing a phosphorylation-mimetic mutant of
Beclin1 S91/94D (SD, denoting mutation of S91 and S94 by
aspartate) showed higher basal activity even in glucose-rich
conditions. In contrast, Vps34 phosphorylation was not required
for VIC3 activation as demonstrated by the fact that the Vps34
T163/165A (SA)-containing VIC3 was similarly activated upon
either glucose starvation or AMPK cotransfection despite having
a higher basal activity (Figure 4A).
To further characterize the role of AMPK-induced phosphory-
lation in the Vps34 complex regulation, we prepared VIC1, VIC2,
and VIC3 from the transfected cells and incubated them with
AMPK in vitro (Figure 4B). Consistent with the in vivo data in Fig-
ure 4A, Beclin1 phosphorylation, but not Vps34 phosphorylation,
was required for VIC3 activation by AMPK in vitro. Interestingly,
Vps34 phosphorylation, but not Beclin1 phosphorylation, was
required for inhibition of the nonautophagy VIC1 and VIC2 by
AMPK in vitro (Figure 4B). These data indicate that the phosphor-
ylation of Beclin1 and Vps34 protein play differential roles in the
regulation of different Vps34 complexes by AMPK.
Atg14L appears to play a critical role in determining the effect,
either activation or inhibition, of AMPK on Vps34 complex regu-
lation. To test this possibility, we immunoprecipitated Vps34
complexes from the transfected cells, in which purified Atg14L
was added to reconstitute the Atg14L-containing Vps34 com-
plex (Figure 4C). Vps34 without Beclin1 (VIC1) was inhibited by
AMPK and the addition of Atg14L did not affect this inhibition
(Figure 4C). This is an expected result because Atg14L partici-
pates in the Vps34 complex via interaction with Beclin1. AMPK
suppressed Vps34-Beclin1 complex (VIC2) activity, but in vitro
Figure 3. AMPK Phosphorylates T163/S165 in Vps34 and S91/S94 in Beclin1
(A) AMPK directly phosphorylates Vps34 and Beclin1 in vitro. The indicated Flag-tagged Vps34 complex proteins were purified from the transfected cells and
tested as substrates for AMPK in vitro by 32P-autoradiogram.
(B) Sequence alignment of the AMPK phosphorylation sites in Beclin1 and other known AMPK substrates.
(C) AMPK is required for glucose-starvation-induced phosphorylation of Beclin1 S91/S94 and Vps34 T163/S165.
(D) Activation of AMPK is sufficient to induce phosphorylation of Vps34 and Beclin1. 293A cells were incubated with compound C (C.C, 20 mM, 30 min) before
glucose starvation. In parallel, 5 mM Metformin (Metf) or 25 mM 2-DG was added in a glucose-rich medium for 3 hr.
See also Figure S3.Atg14L reconstitution reversed the effect of AMPK from
inhibition to activation as shown in Figure 2E. However, the
Atg14L-reconstituted Vps34 complex containing Beclin1 S91/
94A was not activated by AMPK, demonstrating that Beclin1
phosphorylation activates the proautophagy Vps34 complex
(VIC3) by AMPK.
Next, we questioned whether the association of Atg14L in the
Vps34 complex is a prerequisite for activation by AMPK. When
the Vps34-Beclin1 complex was first incubated with AMPK, fol-
lowed by the addition of Atg14L, AMPK pretreatment did not
activate Vps34 lipid kinase activity (Figure 4C), indicating that
Atg14L must be present in the Vps34 complex in order for
AMPK to activate the complex. Notably, AMPK treatment did
not induce any change in the interaction between Beclin1 and
Atg14L (Figure 4C bottom panel). Together, our data demon-strate that AMPK inhibits VIC2 via Vps34 phosphorylation and
activates VIC3 via Beclin1 phosphorylation. Moreover, preas-
sembly of Atg14L on the Vps34 complex is required for VIC3
activation by AMPK, suggesting that binding of Atg14L may
affect phosphorylation of Vps34 and/or Beclin1 by AMPK.
Atg14L Enhances the Activating Phosphorylation of
Beclin1 and Suppresses the Inhibitory Phosphorylation
of Vps34 by AMPK
We investigated the mechanism underlying Beclin1 and Vps34
differential phosphorylation in VIC2 and VIC3 despite the pres-
ence of both proteins in these complexes. To address this ques-
tion, we determined the phosphorylation status of endogenous
Vps34 and Beclin1 in VIC2 and VIC3. Interestingly, we found
that the phosphorylation level of Beclin1 S91/S94 wasCell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 295
Figure 4. Phosphorylation of Beclin1 and Vps34 Is Required for the Regulation of Vps34 Complexes by Glucose Starvation or AMPK
(A) Beclin1 phosphorylation, but not Vps34 phosphorylation, is required for Atg14L-associated Vps34 complex activation in response to glucose starvation. WT,
phosphorylation defective (SA), or phospho-mimetic (SD) Ha-Vps34 was cotransfected with Myc-Beclin1 and Flag-Atg14L in the presence or absence of AMPK
into HEK293 cells as indicated. The cells were glucose-starved for 3 hr (n = 3).
(B) Phosphorylation of Vps34 andBeclin1 is required for Vps34 regulation by AMPK. Vps34 complexeswere immunopurified byHA (Vps34), Myc (Vps34-Beclin1),
or Flag (Vps34-Beclin1-Atg14L) and then incubated with AMPK for 15 min in vitro before Vps34 lipid assay (n = 3). +, WT; A, a phosphorylation-defective mutant.
(C) Atg14L determines whether Vps34-Beclin1 complex is activated or inhibited by AMPK. Vps34 complex was immunopurified by either HA (Vps34) or Myc
(Vps34-Beclin1) from the transfected HEK293 cells, to which purified Atg14L was added and then treated with AMPK as indicated by the arrow for order of the
treatment. Atg14L protein level in the complexes was determined by western blotting (bottom panel) (n = 2).
Data are represented as mean ± SD.significantly higher in VIC3 (Atg14L-IP) than that in VIC2 (Beclin1-
IP) and the opposite was observed for Vps34 T163/S165 phos-
phorylation (Figure 5A). Phosphorylation of Vps34 was low in
VIC3 and unaffected by glucose starvation, whereas phosphor-
ylation of Vps34 in VIC2 was high and robustly induced. In line
with endogenous data, ectopic expression of Atg14L strongly
promoted Beclin1 phosphorylation (Figure S4A) and inhibited
Vps34 phosphorylation (Figure S4B) upon AMPK coexpression.
The above data demonstrate that in the absence of Atg14L,
Vps34, but not Beclin1, is preferentially phosphorylated by
AMPK. In contrast, when Atg14L is in the complex, Beclin1 is
preferentially phosphorylated by AMPK. The majority of endog-296 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.enous Beclin1 is not associated with Atg14L because Atg14L
is limiting (Figures 1B–1D). Therefore, we reasoned that
increased Atg14L expression should enhance Beclin1 phos-
phorylation by AMPK in vivo because more Beclin1 would be
in complex with Atg14L. When Atg14L was overexpressed,
glucose starvation induced a much stronger phosphorylation in
Beclin1 (Figure 5B). It should be noted that endogenous Beclin1
protein level was slightly increased uponAtg14L overexpression.
Two mechanisms may explain these observations: Atg14L
makes Beclin1 a better substrate for AMPK or a poorer sub-
strate for a phosphatase. To this end, we determined the
effect of Atg14L on Beclin1 phosphorylation by AMPK in vitro.
Figure 5. Atg14L Stimulates the Phosphorylation of Beclin1, but Suppresses the Phosphorylation of Vps34 by AMPK
(A) Phosphorylation of Beclin1 and Vps34 is oppositely regulated by glucose starvation in an Atg14L-dependent manner. Endogenous Beclin1 and Atg14L were
immunoprecipitated from glucose-starved MEFs for 3 hr as indicated.
(B) Overexpression of Atg14L increases endogenous Beclin1 phosphorylation. Overexpression of Atg14L was induced in U2OS as Figure 2F. Post Atg14L-IP
denotes the lysate after Atg14L immunoprecipitation, representing the Atg14L (both endogenous and overexpressed)-free fraction.
(C) Atg14L directly enhances Beclin1 phosphorylation by AMPK in vitro. Beclin1 was immunopurified from the transfected HEK293 cells, to which purified Flag-
Atg14L was added. In parallel, Beclin1-Atg14L was obtained from the transfected cells for comparison (co-exp.). The complexes were treated with AMPK for the
indicated time in vitro and the Beclin1 phosphorylation was examined.
(D and E) Determination of the relative phosphorylation of endogenous Vps34 (D) and Beclin1 (E) proteins. The endogenous Vps34 complexes were im-
munopurified fromMEFs with or without glucose as indicated. Relative phosphorylation of Vps34 and Beclin1 was compared with in vitro AMPK-phosphorylated
Vps34 complexes.
See also Figure S4.Vps34-Beclin1 complex, VIC2, was immunopurified from the
transfected cells, to which purified Atg14L was added to recon-
stitute VIC3 in vitro, and then both complexes were phosphory-
lated by AMPK to examine Beclin1 phosphorylation (Figure 5C).
Atg14L dramatically increased the rate and degree of Beclin1
phosphorylation by AMPK. Similarly, Beclin1 was more potently
phosphorylated by AMPK in VIC3 than VIC2 obtained from trans-
fected cells coexpressing Atg14L (Figure S4C). These data
support a model in which Atg14L makes Beclin1 a better
substrate for phosphorylation by AMPK.
To determine the stoichiometry of endogenous Vps34 and Be-
clin1 phosphorylation, we phosphorylated Vps34 and Beclin1
in vitro under maximum AMPK phosphorylation condition, whichpossibly resulted in complete phosphorylation of Vps34 on
T163/S165 and Beclin1 on S91/S94. Comparing the relative
phosphorylation of endogenous Vps34 in VIC1 with the in vitro
phosphorylated Vps34, we estimated that approximately
47.2% of endogenous Vps34 is phosphorylated in VIC1 under
glucose starvation (Figure 5D). Similar experiments with Beclin1
showed that approximately 43.8% of Beclin1 was phosphory-
lated in VIC3 under glucose starvation (Figure 5E). As expected,
AMPK phosphorylated Vps34 more efficiently in VIC1 than VIC3,
whereas it phosphorylated Beclin1 more efficiently in VIC3 than
VIC1. These data indicate that a substantial fraction of Vps34
and Beclin1 in specific Vps34 complexes can be phosphorylated
upon glucose starvation.Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 297
Figure 6. Beclin1 S91/S94 Phosphorylation Is Required for Autophagy Induction
(A) Beclin1 expression level in Beclin1 KD and reconstituted MEFs. Scr denotes scramble shRNA control.
(B) Cells expressing the Beclin1 S91/94A mutant are compromised in LC3 lipidation in response to glucose starvation (n = 3).
(C) Beclin1 S91/S94A mutant is defective in autophagosome formation. The indicated MEFs were starved for glucose for 3 hr and the number of LC3 puncta was
measured by endogenous LC3 staining (top). Also, PI(3)P level was determined by counting the spots of immunostaining using GST-2xFYVE protein as a probe
(middle). The number of LC3 and PI(3)P double-positive puncta was counted by the overlap of LC3 and GST-2xFYVE staining and the percentage was shown
(bottom). Ten to fifteen randomly selected images of the cells, n = 3 are shown. See Figure S5C for confocal images.
(D) Beclin1 S91/84A mutant is defective in autophagy vacuole formation. The indicated MEFs were starved for glucose for 3 hr and the autophagy vacuoles were
examined on electron microscopy (EM). The numbers of autophagosome/autolysosome-like structures (AV) from 15–20 randomly selected cells were counted
(see the representative images in Figures S5D and S6C).
(E) Phosphorylation of Beclin1 S91/S94 is specifically involved in glucose-starvation-induced autophagy. The indicated Beclin1-MEFs were incubated with either
a glucose-free or a 50 nM rapamycin-containing culture medium for 3 hr. Autophagy flux was examined in the presence of 10 mM NH4Cl.
Data are represented as mean ± S.D. See also Figure S5.Beclin1 Phosphorylation Is Required for Autophagy
Induction
To determine the biological function of Beclin1 phosphorylation
by AMPK, we introduced Beclin1-WT and S91/94A mutant (SA)
into the Beclin1 knockdown (Beclin1 KD) MEFs (Figure 6A). It is
worth noting that the knockdown of endogenous Beclin1 was
more efficient in ectopic Beclin1-expressing cells. Consistent
with a critical role of Beclin1 in autophagy, glucose starvation
could not induce autophagy in Beclin1 KD MEFs, as evidenced
by LC3-II accumulation (Figures 6B and S5A). Re-expression
of WT Beclin1 (Beclin1 KD/WT) rescued autophagy defects of298 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.Beclin1 KD MEFs, as indicated by LC3 lipidation (Figure 6B),
p62 degradation (Figure S5B), LC3-positive puncta formation
(Figure 6C), and autophagosome/autolysosome-like vacuole
formation (Figure 6D). Importantly, all autophagic markers were
significantly compromised in Beclin1 KD MEFs expressing
Beclin1 S91/94A (Beclin1 KD/SA), indicating the functional
importance of Beclin1 S91/94 phosphorylation in autophagy in
response to glucose starvation.
Notably, PI(3)P staining, using GST-2xFYVE as a probe,
showed that overall PI(3)P level was decreased upon glucose
starvation (Figure 6C, middle, a quantitative ELISA analysis in
Figure 7D), which is consistent with the previous reports (Gulati
et al., 2008) and our in vitro Vps34 kinase assay showing that
the major Vps34 complexes VIC1 and VIC2 in MEFs were in-
hibited by glucose starvation. However, PI(3)P that colocalized
with LC3 puncta, which were likely generated by proautophagy
Vps34 complexes, was increased upon starvation (Figure 6C,
bottom). To directly monitor autophagy-relevant PI(3)P, we
examined the localization of DFCP1 (an endoplasmic reticulum
(ER)-associated FYVE domain-containing protein that translo-
cates to initiate autophagosome structure and omegasomes
during the starvation condition) using MEFs stably expressing
GFP-DFCP1. Consistently, GFP-DFCP1 puncta were increased
in response to glucose starvation, whereas overall GST-2xFYVE
staining was decreased (Figure S5E), indicating that the auto-
phagy-relevant PI(3)P is specifically increased upon starvation.
These results are consistent with our observation that only
proautophagic Vps34 complexes, such as Atg14L-containing
VIC3, are activated upon the starvation.
To examine whether Beclin1 S91/S94 phosphorylation is
specifically involved in AMPK-dependent autophagy induction,
we examined the effect of rapamycin, an mTORC1 inhibitor,
on LC3-II accumulation. As shown in Figure 6E, both glucose
starvation (AMPK-dependent) and rapamycin treatment
(mTORC1-dependent) induced LC3-II accumulation in Beclin1-
WT-rescued MEFs. However, rapamycin could still induce auto-
phagy in the Beclin1 S91/94A rescued cells, whereas glucose
starvation did not induce LC3-II accumulation. These data indi-
cate that Beclin1 S91/S94 phosphorylation is particularly impor-
tant for glucose starvation and AMPK-dependent autophagy.
Vsp34 Phosphorylation Is Required for Cell Survival
but Not for Autophagy in Response to Starvation
To determine the biological function of Vps34 phosphorylation
by AMPK, we introduced Vps34 WT and T163/165A mutant
(SA) into the Vps34 knockdown (Vps34-KD) MEFs. Although
Vps34 knockdownwas not as efficient as Beclin1 KD (Figure 7A),
it was sufficient to decrease autophagy (Figure S5A). Expression
of either WT or T163/165A mutant rescued autophagy defects
in Vps34-KD MEFs, as measured by LC3-II accumulation
(Figure 7B), p62 degradation (Figure S6A), LC3-positive auto-
phagosome formation (Figure 7C), and autophagosome/autoly-
sosome-like structure formation (Figure 6D). These results are
consistent with our Vps34 lipid kinase assays, in which Vps34
T163/165A mutant did not affect activation of the proautophagy
Vps34 complex by glucose starvation (Figures 4A and 4B). Our
data indicate that phosphorylation of Vps34 by AMPK is not
directly involved in autophagy regulation.
Although not required for autophagy induction, Vps34 phos-
phorylation by AMPK did play a role in overall PI(3)P production
as determined by immunostaining with GST-2xFYVE (Figure 7C).
We found that upon starvation, PI(3)P levels decreased in control
cells or Vps34 WT reconstituted cells but did not decrease in the
Vps34 SA mutant reconstituted MEFs. Quantitative PI(3)P ELISA
assays confirmed that total cellular PI(3)P level was decreased
by glucose starvation in the WT cells (Figure 7D). As expected,
knockdown of Beclin1 or Vps34 reduced basal PI(3)P and abol-
ished the glucose effect on PI(3)P. Re-expression of either WT
Beclin1 or SA mutant restored the glucose-induced regulationof PI(3)P, indicating that Beclin1 phosphorylation is not
required for the decrease of total PI(3)P by glucose starvation.
In contrast, expression of the phosphorylation mutant Vps34
T163/165A could not restore PI(3)P regulation by glucose
starvation (Figures 7C and 7D). These experiments support an
important role of Vps34 phosphorylation in the inhibition of non-
autophagy Vps34 complexes and the decrease of total cellular
PI(3)P production in response to glucose starvation.
We next tested whether inhibition of nonautophagy Vps34
plays a role in stress response by measuring cell survival under
glucose starvation. Knockdown of either Beclin1 or Vps34 signif-
icantly decreased cell viability (Figure 7E and Figure S6D) upon
glucose starvation, consistent with a protective role of auto-
phagy in nutrient starvation. Beclin1 S91/94A-reconstituted cells
were sensitive to glucose starvation, similar to Beclin1 KDMEFs.
Notably, re-expression of Vps34 T163/165A could not rescue
cell death in Vps34-KD cells, even though it rescued the auto-
phagy defects. Therefore, our data suggest that AMPK-induced
phosphorylation inhibits the nonautophagy Vps34 complexes to
protect cells from starvation. These observations support an
important role of inhibition of nonautophagy Vps34 complexes
mediated by AMPK-dependent Vps34 T163/S165 phosphoryla-
tion in cellular starvation response. It is conceivable that some
cellular activity, such as general vesicle trafficking, should be
suppressed upon starvation to preserve energy for survival.
DISCUSSION
Multiple Vps34 complexes are reported to control distinct
cellular processes, such as intracellular vesicle trafficking and
autophagy (Backer, 2008; Obara and Ohsumi, 2011; Vergne
and Deretic, 2010). However, the regulation and coordination
of various Vps34 complexes in response to changing cellular
conditions remain largely unknown. In this study, we provide a
molecular mechanism underlying a dynamic regulation of dif-
ferent Vps34 complexes in response to cellular energy depletion
via the action of AMPK.
AMPK-Mediated Differential Regulation of Vps34
Complexes
Although PI(3)P, a product of Vps34, is believed to recruit auto-
phagy components on the autophagosome membrane, several
studies have documented that Vps34 activity is inhibited and
PI(3)P level is reduced upon starvation (Byfield et al., 2005; Gulati
et al., 2008; Nobukuni et al., 2005). Our study has provided
a mechanistic interpretation for these paradoxical observations.
We have prepared four different Vps34 complexes by immuno-
precipitation against characteristic Vps34 complex subunits or
by fractionation of highly enriched individual Vps34 complexes
(VIC1-VIC4). Within the linear Vps34 lipid kinase assay condition
(Figure S7A), we show that Vps34 complexes that are free of
autophagy-specific subunits, Atg14L and UVRAG, are inhibited
by glucose starvation. This is accomplished by the inhibitory
phosphorylation of Vps34 T163/S165 by AMPK. In contrast,
the proautophagy Vps34-containing Atg14L is activated via
phosphorylation of Beclin1 S91/S94 by AMPK.
Both inhibitory and activating effects of glucose starvation on
non- and proautophagy Vps34 complexes were blunted inCell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 299
Figure 7. Vsp34 Phosphorylation Is Required for Cell Survival but Not Autophagy in Response to Starvation
(A) Vps34 expression level in Vps34-MEFs.
(B and C) The Vps34 T163/S165A mutant does not compromise autophagy induction in response to glucose starvation as evidenced by LC3 lipidation (B) and by
LC3-positive puncta formation (C). See Figure S6B for confocal images.
(D) Vps34 phosphorylation is required for PI(3)P reduction in response to glucose starvation. The PI(3)P level in glucose-starved MEFs was determined by
quantitative PI(3)P ELISA assay. The PI(3)P level was normalized by the amount of proteins used in the assay (n = 6; *p < 0.05; **p < 0.01).
(E) Vps34 phosphorylation is required for cell survival in response to glucose starvation. Beclin1 or Vps34-MEF cells were starved for glucose for 24 hr and then
the viability was measured by FACS analysis using AnexinV and propidium iodide (PI) double-staining (n = 4; **p < 0.01).
(F) A schematic model of Vps34 regulation by AMPK in response to energy starvation.
Data are represented as mean ± S.D. See also Figure S6.AMPK-DKO MEFs, clearly demonstrating the role of AMPK in
these regulations. We may consider the complication that the
autophagy defect in AMPK-DKO MEFs is due to the metabolic
changes caused by the loss of AMPK, which results in a
decrease of glucose usage and lactate formation at 24 hr (Fig-
ure S7B). However, these differences should not affect our anal-
ysis because cells were harvested at 3 hr. Moreover, the AMPK
phosphorylation-defective Vps34 (or Beclin1) mutant was no
longer regulated by the starvation, similar to the Vps34 complex
in AMPK-DKO MEFs, indicating that the Vps34 regulation
observed in our study is directly linked to AMPK activity.
Notably, most of Vps34 is not in complex with Atg14L or
UVRAG, suggesting that the majority of Vps34 is in nonautoph-
agy complexes, particularly in MEFs. In agreement with the
analyses of Vps34 complex subunit proteins by immunoprecipi-300 Cell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc.tations, Atg14L and UVRAG were hardly detected in the Vps34
preparation by streptavidin pull-down (Figure S7C) and its lipid
kinase activity was also inhibited by glucose starvation (Figure
S7D). Similarly, Beclin1-containing complexes were prepared
by either streptavidin pull-down or anti-Beclin1 immunoprecipi-
tation. Vps34 kinase activity of both Beclin1 preparations was
similarly inhibited by glucose starvation (Figure S7E). These
data demonstrate that results from the nonautophagy Vps34
complexes (Vps34-IP and Beclin-IP) in this study were not due
to an artifact in the kinase assay caused by antibodies.
Autophagy can be induced by multiple stresses via different
signaling mechanisms. Several kinases, such as JNK, DAPK,
and CDK1/5, have been demonstrated to regulate Vps34
complexes by modulating the Vps34-Beclin1 interaction in
response to stresses including nutrient starvation (Furuya
et al., 2010; Wei et al., 2008; Zalckvar et al., 2009). However, we
did not observe any significant change in the interaction between
Vps34 and Beclin1 upon glucose starvation, consistent with
a previous report (Byfield et al., 2005). It was recently reported
that CCCP, a mitochondrial uncoupler that activates AMPK,
induces autophagy in a manner dependent on mTORC1, but
not AMPK (Kwon et al., 2011). This suggests that mammalian
autophagy is controlled by multiple layers of regulation, in which
AMPK and mTORC1 may function cooperatively (for example,
for ULK1 regulation) or differently (such as CCCP), depending
on the stress. In the case of nutrient starvation, we observed
that amino acid starvation, which relies on mTORC1 to activate
autophagy, also differentially regulates Vps34 complexes in
comparison to glucose starvation (data not shown). Therefore,
the activation of autophagy-specific Vps34 complexes and the
inhibition of the nonautophagy complex seem to be a common
mechanism in autophagy in response to nutrient starvation.
However, phosphorylation of Beclin1 S91/S94 is selectively
required for glucose starvation and AMPK-dependent, but not
rapamycin-induced, autophagy (Figure 6E).
Atg14L Determines Whether a Vps34 Complex Is
Activated by AMPK
The autophagy-specific subunit Atg14L targets the Vps34
complex to the ER for autophagy (Matsunaga et al., 2010). Our
study reveals another critical role of Atg14L: to function as
a switch that converts the inhibitory effect of AMPK (or glucose
starvation) on Vps34 complex to an activation effect. Atg14L
functions not only to prevent the inhibitory phosphorylation in
Vps34, but also to promote the activating phosphorylation in Be-
clin1 by AMPK. As a result, we found that ectopic expression of
Atg14L increased Beclin1 phosphorylation (Figure 5B) as well as
autophagy level (Figure S7F), possibly due to the increase of
proautophagy VIC3 population. We speculate that Atg14L
binding may induce conformational changes in the Vps34
complex to interfere with the availability of T163/S165 in Vps34
and promote the availability of S91/S94 in Beclin1 for phosphor-
ylation by AMPK. We also found that another proautophagy
Vps34 complex containing UVRAG is regulated by AMPK-
dependent phosphorylation as an Atg14L-containing complex
(Figure S2C). UVRAG may act in a manner similar to Atg14L in
Vps34 regulation. Indeed, UVRAG has been proposed to induce
Beclin1 conformational changes, thus activating the Vps34
complex (Noble et al., 2008). However, the overexpression of
UVRAG could not rescue the loss of Atg14L in autophagy induc-
tion in response to glucose starvation (Figure S7G), which may
support the current understanding that Atg14L and UVRAG
function in initiation and maturation of autophagy, respectively.
Biology of Differential Regulation of Vps34 Complexes
We showed that glucose starvation decreases overall PI(3)P
levels, but the pool of autophagy-related PI(3)P is increased,
indicating that there are discrete functions for the different
PI(3)P pools produced by different Vps34 complexes in cellular
adaptation to stress. Local activation of the proautophagy
Vps34 complex labels the membrane with PI(3)P for initiation
and growth of autophagosome membrane, where LC3 protein
is localized. Supporting a role of the local PI(3)P in autophagy,LC3/GFP-2xFYVE double-positive puncta are not increased by
starvation in Beclin1 S91/94A-reconstituted MEFs, which are
defective in autophagy induction. The decrease in total PI(3)P
levels appears to be a consequence of the inhibition of the
nonautophagy Vps34 complexes because cells expressing the
nonphosphorylatable Vps34 T163/165A mutant could not
decrease PI(3)P in response to starvation. Therefore, distinct
Vps34 complexes appear to be responsible for production of
different cellular pools of PI(3)P. Our data also show that the
regulation of nonautophagy Vps34 complexes by AMPK is
also important for stress response, as cells expressing the
Vps34 T163/165A mutant are sensitive to starvation although
autophagy remains normal. Knockdown of Vps34 in MEF did
not show significant defects in endocytosis and trafficking,
such as EGFR degradation, or in Cathepsin D processing, but
resulted in dramatic retardation of cell growth and proliferation
(data not shown), similar to a previous study of U-251 glioblas-
toma (Johnson et al., 2006). We observe that the defect in cell
proliferation is significantly restored by expression of either the
WT or the phosphorylation mutant Vps34 (data not shown).
One may speculate that a decrease of nonautophagy PI(3)P
reduces cellular activities associated with cell growth and
proliferation to maintain cell viability upon starvation. In fact,
accumulating evidence supports the function of Vps34 in the
cell cycle, growth, and cytokinesis (Furuya et al., 2010; Gulati
et al., 2008; Sagona et al., 2010). Therefore, inhibition of nonau-
tophagy Vps34 represents an important, although little under-
stood, aspect of the cellular stress response. In this study, we
have not tested different localizations of these different Vps34
complexes in cells due to the lack of antibodies suitable for
immunostaining. GFP-fusion proteins have been widely used
to examine the localization of the Vps34 complex. However,
we should consider the possibility of its artifact due to the
expression levels of the target proteins. In particular, the stoichi-
ometry of distinct Vps34 is very sensitive to the Vps34 complex
protein level. For example, we found that Beclin1 phosphoryla-
tion was increased upon ectopic Atg14L expression (Figure 5B),
indicating that the VIC3 subpopulation is increased. Therefore,
we were not comfortable presenting these overexpression-
based immunofluorescence results. Indeed, when we tried to
establish immunofluorescence of tagged Vps34 complexes
(Vps34, Beclin1, or Atg14L) in MEFs, we realized that it was
impractical to obtain expression of all subunits at the same
levels as the endogenous proteins. There is indirect evidence
showing different localization of Atg14L and UVRAG and, more-
over, a partial overlap of Vps34 with either Atg14L or UVRAG
(Itakura et al., 2008).
In this study, we demonstrate that AMPK is necessary and
sufficient for Vps34 regulation upon glucose starvation. Previ-
ously, we and others have shown AMPK in ULK1 regulation
(Egan et al., 2011; Kim et al., 2011). Although lines of evidence
indicate ULK1 acting upstream of Vps34 (Di Bartolomeo et al.,
2010; Itakura andMizushima, 2010), it is unclear howULK1 regu-
lates Vps34. Some reports show that ULK1 is dispensable for
autophagy, possibly explained by redundancy with ULK2
(Cheong et al., 2011; Egan et al., 2011). The lack of constitutively
active ULK1 or Vps34 hampers us to reach a definitive
conclusion. Interestingly, we observed that long-term glucoseCell 152, 290–303, January 17, 2013 ª2013 Elsevier Inc. 301
starvation could activate ULK1-independent autophagy (Fig-
ure S7H), whereas ULK1 is required for the short-term starvation
(Figure S7I). In contrast, the Vps34 complex is necessary for both
short- and long-term starvation, revealing the complexity of
autophagy regulation.
In conclusion, this study reveals a molecular mechanism for
the differential regulation of different Vps34 complexes under
energy starvation (Figure 7F), in which AMPK inhibits the nonau-
tophagy Vps34 complexes by phosphorylating Vps34 and
activates proautophagy Vps34 complexes by phosphorylating
Beclin1. The presence of the autophagy factor Atg14L inhibits
Vps34 phosphorylation and promotes Beclin1 phosphorylation,
thereby converting the AMPK-mediated inhibition of Vps34 to
activation.
EXPERIMENTAL PROCEDURES
Antibodies and Reagents
Anti-phospho-Beclin1 S91/S94 and Vps34 T163/S165 antibodies were gener-
ated by immunizing rabbits with the corresponding phosphopeptides, and the
phosphospecific antibodies were affinity purified (Cell Signaling Technology).
The details on other antibodies and the reagents can be found in the Extended
Experimental Procedures.
Cell Death and PI(3)P-ELISA Assays
Cell viability was determined by trypan blue staining and the apoptotic cells
were examined by Annexin V/propidium iodide (PI) staining. The total amount
of PI(3)P was measured by a quantitative ELISA assay (Echelon Biosciences).
See the Extended Experimental Procedures for details.
AMPK Kinase Assay
Bacterial-purified GST-Beclin1 or GST-Vps34 proteins were used as sub-
strates for AMPK in vitro phosphorylation. See the Extended Experimental
Procedures for details.
Immunofluorescence Staining and Image Quantification
LC3 puncta and total cellular PI(3)P were stained by anti-LC3 antibody (Cell
Signaling Technology) and biotinylated-GST-2xFYVE proteins, respectively.
Staining images were analyzed on a Zeiss LSM confocal microscope. See
the Extended Experimental Procedures for details on immunostaining steps
and image quantification.
Electron Microscopy
MEF cells were starved for glucose for 3 hr, fixed in a modified Karnovsky’s
fixative (1.5% glutaraldehyde, 3% paraformaldehyde, and 5% sucrose in
0.1 M cacodylate buffer [pH 7.4]), and then stained with uranyl acetate and
lead nitrate. The details on electron microscopy analysis are shown in the
Extended Experimental Procedures.
In Vitro Vps34 Lipid Kinase Assay
Vps34 immune complexes were incubated in a buffer (20 mM HEPES, 1 mM
EGTA, 0.4 mM EDTA, 5 mM MgCl2, 0.05 mM DTT, 50 mM ATP, 5 mM
MnCl2, and 50 mM DTT [pH 7.4]) containing 0.1 mg/ml PI and 5 mCi
32P-
ATP at 37C for 30 min. Reactions were terminated by adding 1/5 vol of
1N HCl, and the lipid was extracted by 2 vol of CHCl3:MeOH (1:1).
32P-
PI(3)P was separated on a thin-layer-chromatography plate (Whatman)
under CHCl:MeOH:NH4OH:Water (129:100:4.29:24) mixture and detected
by autoradiograph.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
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